The 50mg intranasal spray formulation provides additional scientific value by allowing laboratories to investigate formulation stability, spray consistency, peptide integrity, copper complex stability, physicochemical characteristics, analytical reproducibility, and intranasal delivery system performance
Retatrutide is an investigational once-weekly injectable developed by Eli Lilly for obesity, type 2 diabetes, and related metabolic conditions
See our full breakdown in is BPC-157 banned by WADA
Ann Intern Med 64:817, 1966
Report ID: 7667 Published Date: Aug 25, 2025 Report Format: PDF, PPT (FAQ)
The liver metabolizes many toxins and eliminates them in bile first through the gallbladder and then the colon